Paul van Damme

Paul van Damme

Direttore/Membro del Consiglio presso XORTX THERAPEUTICS INC.

Patrimonio netto: 18 308 $ in data 31/05/2024

Health Technology
Commercial Services
Finance

Profilo

Paul Joseph van Damme currently works at Ontario Genomics Institute, as Director, Wildlaw Capital Markets, Inc., as Managing Director, XORTX Therapeutics, Inc., as Independent Director from 2018, and WD Capital Markets, Inc., as Managing Director.
Mr. van Damme also formerly worked at Quest PharmaTech, Inc., as Independent Director from 2012 to 2015, ZipLocal, Inc., as Chief Financial Officer & Director from 2012 to 2016, Insception Biosciences, Inc., as Director, Structural Genomics Consortium, as Chief Financial Officer, Secretary & Director from 2012 to 2019, Ontario Genomics Institute (Private Equity), as Director, XORTX Pharma Corp., as Director, OncoQuest, Inc., as Director from 2015 to 2020, Aptose Biosciences, Inc., as Chief Financial Officer from 2004 to 2005, Vasogen, Inc., as CFO in 2007, Bradmer Pharmaceuticals, Inc., as Chief Financial Officer from 2007 to 2018, Allelix Biopharmaceuticals, Inc., as Chief Financial Officer, NXA, Inc., as Chief Financial Officer, Crosswinds Holdings, Inc., as Chief Financial Officer from 2013 to 2015, PricewaterhouseCoopers, Inc., as Principal, Laidlaw, Inc. (Connecticut), as Chief Financial Officer, Canada Systems Group Ltd., as Chief Financial Officer in 1991, Junior Achievement of Central Ontario, as Chief Financial Officer, Ellipsiz Communications Ltd., as Chief Financial Officer from 2011 to 2015, Galaxy Digital Holdings Ltd., as Chief Financial Officer, and Mind Medicine (MindMed), Inc., as Chief Financial Officer in 2020.
Mr. van Damme received his Masters Business Admin degree from Rotman School of Management and undergraduate degree from the University of Toronto.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
04/03/2024 7 110 ( 0.36% ) 18 308 $ 31/05/2024

Posizioni attive di Paul van Damme

SocietàPosizioneInizio
XORTX THERAPEUTICS INC. Direttore/Membro del Consiglio 25/01/2018
Corporate Officer/Principal -
Ontario Genomics Institute Direttore/Membro del Consiglio 20/10/2010
Corporate Officer/Principal -
Tutte le posizioni attive di Paul van Damme

Precedenti posizioni note di Paul van Damme

SocietàPosizioneFine
MIND MEDICINE (MINDMED) INC. Direttore Finanziario/CFO 01/04/2020
Direttore/Membro del Consiglio 01/02/2020
Direttore Finanziario/CFO 31/05/2019
GALAXY DIGITAL HOLDINGS LTD. Direttore Finanziario/CFO 31/07/2018
Direttore Finanziario/CFO 01/07/2018
Vedi nel dettaglio l'esperienza di Paul van Damme

Formazione di Paul van Damme

Rotman School of Management Masters Business Admin
University of Toronto Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Paul van Damme

Relazioni

57

Relazioni di 1° grado

26

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa5
APTOSE BIOSCIENCES INC.

Health Technology

QUEST PHARMATECH INC.

Commercial Services

XORTX THERAPEUTICS INC.

Health Technology

GALAXY DIGITAL HOLDINGS LTD.

Commercial Services

MIND MEDICINE (MINDMED) INC.

Health Technology

Aziende private19

Health Technology

Commercial Services

Allelix Biopharmaceuticals, Inc.

Health Technology

Non-Energy Minerals

Health Technology

Commercial Services

Finance

Commercial Services

Laidlaw, Inc. (Connecticut)

Transportation

Canada Systems Group Ltd.

Miscellaneous

Ontario Genomics Institute

Finance

Commercial Services

Finance

Health Technology

Health Technology

Communications

Finance

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Paul van Damme